Broderick Brian C Gilead Sciences, Inc. Transaction History

Broderick Brian C

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $528,816 - $690,065	-8,735 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$71.28 - $78.92 $579,007 - $641,067	-8,123 Reduced 48.18%	8,735 $675,000
Q2 2018 Jul 30, 2018	BUY	$64.88 - $75.68 $2,270 - $2,648	35 Added 0.21%	16,858 $1.19 Million
Q1 2018 Apr 24, 2018	BUY	$72.84 - $88.8 $30,447 - $37,118	418 Added 2.55%	16,823 $1.27 Million
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $18,356 - $21,548	-258 Reduced 1.55%	16,405 $1.18 Million
Q3 2017 Oct 26, 2017	BUY	$72.11 - $85.47 $1.2 Million - $1.42 Million	16,663	16,663 $1.35 Million

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

Stay updated on Broderick Brian C with notifications on news.